Mandate Details

Description:	Report on the implementation of prescription drug price transparency under this section, including promoting transparency in pharmaceutical pricing for the state and other payers; enhancing the understanding on pharmaceutical spending trends; and assisting the state and other payers in the management of pharmaceutical costs.The report must include a summary of the information that drug manufacturers submit under Subs. 3, 4, and 5.
Law:	2020 Minn. Laws Chap. 78 Sec. 1 Subd. 9
Statute:	62J.84 Subd. 9
Agency(ies)/Supplier(s):	Minn. Dept. of Health
Due Date:	01/15/2024
Frequency:	Annual
Subjects:	Health Care - Costs & Financing Health Care - Pharmaceuticals
Committee/Agency Jurisdiction:	Commerce Health and Human Services Policy and Finance
Note:	The Minn. Dept. of Health plans to publish this report in the first week of the 2024 legislative session.

Title	Publisher(s)	Publication Date	Coverage	Date Received	Report Link	Call #
Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature	Minn. Dept. of Health	September 8, 2023	Through November 2022	09/11/2023	23-1462.pdf
Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature		February 2023	First half of 2022	03/15/2023	23-0635.pdf	HD9665.4 .M566 2023